98%
921
2 minutes
20
Purpose: To explore the optimized concentration of AAV2-GFP for sparse transfection of retinal ganglion cells (RGCs) and optic nerve (ON), and to examine the changes of microglial morphology and distribution in the retina, optic nerve and chiasm after injection.
Methods: We defined the optimal concentration of AAV2-GFP for sparse labeling of RGCs and axons in WT mice. We further explored the changes of microglial morphology and distribution in the retina, optic nerve and chiasm after intravitreal injection in CX3CR1+/GFP mice.
Results: 14 days after intravitreal injection of AAV2-GFP, live imaging of the retina showed that fundus fluorescence was very strong and dense at 2.16 × 10 VG/retina, 2.16 × 10 VG/retina, 2.16 × 10 VG/retina. RGCs were sparsely marked at a concentration 1:1000 (2.16 × 10 VG/retina) and fundus fluorescence was weak. The transfected RGCs and axons were unevenly distributed in the retina and significantly more RGCs were transfected near the injection site of AAV2-GFP compared to the other sites of the flat-mounted retina. Microglia density increased significantly in the retina and part of optic nerve, but not in the optic chiasm. The morphology of microglia was largely unchanged.
Conclusions: AAV2-GFP was highly efficient and the optimal concentration of sparsely labeled RGCs was 1:1000 (2.16 × 10 VG/retina). After intravitreal injection of AAV2-GFP, the number of microglia increased partly. The morphology of microglia was comparable.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1177/11206721211049001 | DOI Listing |
Nat Commun
September 2025
Shanghai Yao Yuan Biotechnology Ltd (Drug Farm), Shanghai, China.
ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome is a rare genetic disease caused by variants in alpha-kinase 1 (ALPK1) resulting in downstream pro-inflammatory signaling mediated by the TIFA/TRAF6/NF-κB pathway. Here, we report the design of an ALPK1 inhibitor, DF-003, with pharmacokinetic properties suitable for daily oral dosing. In biochemical assays, DF-003 potently inhibits human ALPK1 (IC = 1.
View Article and Find Full Text PDFOphthalmic Plast Reconstr Surg
September 2025
Purpose: During endoscopic endonasal access to small intraconal masses deep in the orbital apex, a line of fusion between inferior and medial recti is encountered distal to the termination of the common tendinous ring. The intraoperatively viewed length of this segment has not been quantified. To assist clinical recognition of this structure, our study quantifies its length and proposes the standardized nomenclature term of inferomedial extraocular muscle raphe (IM-EOMR).
View Article and Find Full Text PDFRetina
September 2025
From the Vitreous, Retina, Macula Consultants of New York, New York, NY.
Purpose: To reassess the anatomic basis of optic disc pit maculopathy (OPM) using swept-source optical coherence tomography (SS-OCT) and to characterize the broader structural abnormalities comprising the optic pit complex.
Methods: Sixteen patients with OPM were imaged using a high-resolution SS-OCT system (DREAM OCT). Cross-sectional and volume-rendered scans were analyzed for lamina cribrosa defects, intraneural cavitations, and pathways for fluid entry into or beneath the retina.
Neurol Res
September 2025
Department of Neurosurgery, Xingtai Central Hospital, Xingtai, China.
Objective: To investigate the prognostic significance of concurrent monitoring of serum S100 calcium-binding protein A12 (S100A12) and optic nerve sheath diameter (ONSD) in patients with traumatic intracranial hematoma.
Methods: This prospective observational study included 198 patients with traumatic intracranial hematoma from Xingtai Central Hospital (February 2022-June 2024). Serum S100A12 and ONSD were measured at admission and postoperatively, and patients received minimally invasive therapy.
Metabolomics
September 2025
Laboratoire de Biochimie et Biologie Moléculaire, Centre Hospitalier Universitaire, Angers, France.
Introduction: The definition of Leber's hereditary optic neuropathy (LHON) does not take into account a preclinical phase during which the thickness of retinal nerve fiber layer (RNFL) is increased, prior to optic nerve atrophy, reducing the chances of visual recovery.
Objectives: Search for a metabolomic signature characterizing this preclinical phase and identify biomarkers predicting the risk of LHON onset.
Methods And Results: The blood and tear metabolomic profiles of 90 asymptomatic LHON mutation carriers followed for one year will be explored as a function of RNFL thickness and compared to those of a healthy control.